AAAAAA

   
Results: 1-8 |
Results: 8
SUMATRIPTAN SUPPOSITORIES FOR THE ACUTE TREATMENT OF MIGRAINE
Authors: TEPPER SJ COCHRAN A HOBBS S WOESSNER M
Citation: Sj. Tepper et al., SUMATRIPTAN SUPPOSITORIES FOR THE ACUTE TREATMENT OF MIGRAINE, International journal of clinical practice, 52(1), 1998, pp. 31-35
MEDIA TECHNOLOGIES AND ECONOMIC-DEVELOPMENT - A FRAMEWORK FOR THE INFORMATION-SOCIETY
Authors: WOESSNER M
Citation: M. Woessner, MEDIA TECHNOLOGIES AND ECONOMIC-DEVELOPMENT - A FRAMEWORK FOR THE INFORMATION-SOCIETY, Internationale Politik, 53(8), 1998, pp. 1-6
CONSISTENCY OF RESPONSE TO SUMATRIPTAN NASAL SPRAY ACROSS PATIENT SUBGROUPS AND MIGRAINE TYPES
Authors: ASHFORD E SALONEN R SAIERS J WOESSNER M
Citation: E. Ashford et al., CONSISTENCY OF RESPONSE TO SUMATRIPTAN NASAL SPRAY ACROSS PATIENT SUBGROUPS AND MIGRAINE TYPES, Cephalalgia, 18(5), 1998, pp. 273-277
DURABILITY OF HBEAG SEROCONVERSION AFTER LAMIVUDINE MONOTHERAPY IN CONTROLLED PHASE-II AND PHASE-III TRIALS
Authors: SCHIFF E CIANCIARA J KOWDLEY K NORKRANS G PERRILLO R TONG M CROWTHER L WAKEFORD J WOESSNER M STEVENSON C BROWN N
Citation: E. Schiff et al., DURABILITY OF HBEAG SEROCONVERSION AFTER LAMIVUDINE MONOTHERAPY IN CONTROLLED PHASE-II AND PHASE-III TRIALS, Hepatology, 28(4), 1998, pp. 1-1
CLINICAL-SIGNIFICANCE OF YMDD MUTANT HEPATITIS-B VIRUS (HBV) IN A LARGE COHORT OF LAMIVUDINE-TREATED HEPATITIS-B PATIENTS
Authors: ATKINS M HUNT CM BROWN N GRAY F SANATHANAN L WOESSNER M LAI CL DUSHEIKO G DIENSTAG J WRIGHT T BARNARD J BOURNE E CONDREAY L
Citation: M. Atkins et al., CLINICAL-SIGNIFICANCE OF YMDD MUTANT HEPATITIS-B VIRUS (HBV) IN A LARGE COHORT OF LAMIVUDINE-TREATED HEPATITIS-B PATIENTS, Hepatology, 28(4), 1998, pp. 625-625
A PLACEBO-CONTROLLED STUDY OF LAMIVUDINE AND INTERFERON-ALPHA-2B IN PATIENTS WITH CHRONIC HEPATITIS-B WHO PREVIOUSLY FAILED INTERFERON THERAPY
Authors: SCHIFF E KARAVALCIN S GRIMM I PERRILLO R DIENSTAG J HUSA P SCHALM S CROWTHER L SULLIVAN M WOESSNER M MCPHILLIPS P BROWN N
Citation: E. Schiff et al., A PLACEBO-CONTROLLED STUDY OF LAMIVUDINE AND INTERFERON-ALPHA-2B IN PATIENTS WITH CHRONIC HEPATITIS-B WHO PREVIOUSLY FAILED INTERFERON THERAPY, Hepatology, 28(4), 1998, pp. 901-901
CLINICAL SAFETY PROFILE OF LAMIVUDINE TREATMENT IN A LARGE COHORT OF HEPATITIS-B PATIENTS
Authors: LEUNG N DIENSTAG J SCHIFF E SULLIVAN M ATKINS M GRICE R WOESSNER M BROWN N HUNT CM
Citation: N. Leung et al., CLINICAL SAFETY PROFILE OF LAMIVUDINE TREATMENT IN A LARGE COHORT OF HEPATITIS-B PATIENTS, Hepatology, 28(4), 1998, pp. 1698-1698
LAMIVUDINE TREATMENT FOR ONE-YEAR IN PREVIOUSLY UNTREATED US HEPATITIS-B PATIENTS - HISTOLOGIC IMPROVEMENT AND HEPATITIS BE-ANTIGEN (HBEAG)SEROCONVERSION
Authors: DIENSTAG J SCHIFF E WRIGHT T PERRILLO R HANN HW CROWTHER L WOESSNER M RUBIN M BROWN N
Citation: J. Dienstag et al., LAMIVUDINE TREATMENT FOR ONE-YEAR IN PREVIOUSLY UNTREATED US HEPATITIS-B PATIENTS - HISTOLOGIC IMPROVEMENT AND HEPATITIS BE-ANTIGEN (HBEAG)SEROCONVERSION, Gastroenterology, 114(4), 1998, pp. 148-148
Risultati: 1-8 |